Bayer is a large German pharmaceutical company with a strong global presence due to its innovation, portfolio management, and clear organizational structure. The document discusses Bayer's sustainability strategies, culture framework, situation analysis using a balanced scorecard, and implications for expansion through acquisitions or discontinued operations. Strategic recommendations include improving crop science, increasing marketing to overcome substitutes, reinforcing partnerships, and better disclosing side effects to reduce lawsuits.
Bayer is a large German pharmaceutical company with a strong global presence due to its innovation, portfolio management, and clear organizational structure. The document discusses Bayer's sustainability strategies, culture framework, situation analysis using a balanced scorecard, and implications for expansion through acquisitions or discontinued operations. Strategic recommendations include improving crop science, increasing marketing to overcome substitutes, reinforcing partnerships, and better disclosing side effects to reduce lawsuits.
Bayer is a large German pharmaceutical company with a strong global presence due to its innovation, portfolio management, and clear organizational structure. The document discusses Bayer's sustainability strategies, culture framework, situation analysis using a balanced scorecard, and implications for expansion through acquisitions or discontinued operations. Strategic recommendations include improving crop science, increasing marketing to overcome substitutes, reinforcing partnerships, and better disclosing side effects to reduce lawsuits.
Bayer is a large German pharmaceutical company with a strong global presence due to its innovation, portfolio management, and clear organizational structure. The document discusses Bayer's sustainability strategies, culture framework, situation analysis using a balanced scorecard, and implications for expansion through acquisitions or discontinued operations. Strategic recommendations include improving crop science, increasing marketing to overcome substitutes, reinforcing partnerships, and better disclosing side effects to reduce lawsuits.
German multinational, pharmaceutical and ENTRY STRATEGIES life science company. Acquisitions Strong innovation and a great portfolio Sustainability strategies framework Discontinued operations management alongside with clear structure (Bayer, 2018) defined have lead Bayer to a sustained Consolidated companies competitive advantage, strong presence in Adaptation approach the global market and easily accommodate CULTURE FRAMEWORK subsidiaries under Bayer culture. SITUATION ANALYSIS SUCESSFULL STRATEGIES BALANCE SCORECARD TOWS OUTCOME SO: Keep improving in crop science as there is a growing industry which is the second source of revenue for Bayer. ST: Increase the marketing force to overcome the low-cost substitutes. WO: Reinforce their partnership to reduce the risk in biotech products segment. WT: Mayor disclosure of side effects to ETHICS reduce the lawsuits. PORTER VALUE CHAIN MANAGERIAL IMPLICATIONS